It is a bit confusing. There should be a more comprehensive treatment of all of the data for the conference but I don't think there is room for upside surprise for two reasons. 1. We already know so much about 201 2. The data release from early 202 eclipses the importance of 201 because of the larger N and the better control chemo regimen.
News 
Market Data 
Discover 
